Efficacy and Safety of Topical Clascoterone Cream 1% in Patients With Facial Acneiform Rosacea
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Men and women ages 18+.
• Diagnosis of rosacea type 2 (papulopustular).
• Available and willing to comply with study instructions and attend all study visits.
• Able and willing to provide written and verbal informed consent.
• Subject has used the same type and brand of make-up, other facial products, and hair products (e.g., shampoo, gel, hair spray, mousse, etc.) for at least one month prior to the baseline visit and agrees to continue his/her other general skin and hair care products and regimen for the entire study.
Locations
United States
New York
New York Harbor VA Brooklyn Campus
RECRUITING
Brooklyn
Contact Information
Primary
Kayla N Zafar, BA
kayla.zafar@va.gov
718-836-6600
Time Frame
Start Date: 2025-03-14
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 20
Treatments
Experimental: Patients with Acneiform or Papulopustular Rosacea
Patients with diagnosis of papulopustular or acneiform rosacea
Related Therapeutic Areas
Sponsors
Collaborators: Sun Pharmaceutical Industries Limited
Leads: Narrows Institute for Biomedical Research